跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 80 条关于
“Palmoplantar Keratoderma”
全部
80
临床试验
62
药物
1
机构
0
资讯
17
去年
Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Trials to the UK
10个月前
Quoin Pharmaceuticals Achieves High-Concentration Topical Rapamycin Formulations for Rare Vascular Malformations
10个月前
MoonLake's Sonelokimab Shows Promise in Palmoplantar Pustulosis Phase 2 Trial, Advances Toward BLA Submission
去年
LEO Pharma Launches Phase 2a Trial of Delgocitinib Cream for Rare Skin Disease Palmoplantar Pustulosis
2年前
Ixekizumab Shows Sustained Efficacy in Treating Psoriasis in Challenging Body Areas Over 5 Years
去年
Kamari Pharma Secures $23 Million Series A to Advance First-in-Class TRPV3 Inhibitor for Rare Genetic Skin Diseases
去年
MoonLake Launches Three Clinical Trials for Sonelokimab in Inflammatory Diseases
11个月前
MoonLake's Sonelokimab Shows Promise in Teen HS Patients Despite Adult Trial Setbacks
去年
Bimekizumab Shows Efficacy and Safety in Elderly Psoriasis Patients
去年
MoonLake Immunotherapeutics Affirmed with Buy Rating for Strategic Clinical Expansion
第 1 页,共 2 页
上一页
下一页